IPHC-E Repository System

Pharmaceutical products traceability master data guideline, version 002

Show simple item record

dc.contributor.author Ethiopian Food and Drug Authority
dc.date.accessioned 2026-02-24T10:24:27Z
dc.date.available 2026-02-24T10:24:27Z
dc.date.issued 2022
dc.identifier.uri http://repository.iphce.org/xmlui/handle/123456789/5357
dc.description.abstract Ethiopia has made great strides to improve access to safe, quality and efficacious pharmaceutical products to the public. The EFDA is responsible for ensuring the safety, quality and efficacy of pharmaceutical products circulating in the market. The availability of substandard and falsified (SF), and illegally circulating medicine with unknown sources negatively impacts patient safety. In addition, the inefficient recall system, and lack of visibility in pharmaceutical products movement among the pharmaceutical supply chain actors and within organizations, hinders the supply chain from functioning efficiently. This has forced the government to implement a system that ensures traceability of pharmaceutical products that spans from manufacturer to end-users. en_US
dc.language.iso en_US en_US
dc.subject Pharmaceuticals en_US
dc.title Pharmaceutical products traceability master data guideline, version 002 en_US
dc.type Guideline en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search IPHC-E Repository


Browse

My Account